JP2022520817A5 - - Google Patents
Info
- Publication number
- JP2022520817A5 JP2022520817A5 JP2021547401A JP2021547401A JP2022520817A5 JP 2022520817 A5 JP2022520817 A5 JP 2022520817A5 JP 2021547401 A JP2021547401 A JP 2021547401A JP 2021547401 A JP2021547401 A JP 2021547401A JP 2022520817 A5 JP2022520817 A5 JP 2022520817A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- composition according
- pharmaceutical composition
- containing seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962806237P | 2019-02-15 | 2019-02-15 | |
| US62/806,237 | 2019-02-15 | ||
| PCT/CA2020/050195 WO2020163962A1 (en) | 2019-02-15 | 2020-02-14 | Fcmr-binding molecules and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022520817A JP2022520817A (ja) | 2022-04-01 |
| JP2022520817A5 true JP2022520817A5 (cg-RX-API-DMAC7.html) | 2023-02-21 |
Family
ID=72043773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547401A Pending JP2022520817A (ja) | 2019-02-15 | 2020-02-14 | Ｆｃｍｒ結合分子およびそれらの使用 |
Country Status (14)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021009767A (es) | 2019-02-15 | 2021-11-17 | Univ Health Network | Moleculas de union de fmcr y usos de las mismas. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| AU2004297616B2 (en) | 2003-12-04 | 2008-12-18 | Xencor, Inc. | Methods of generating variant proteins with increased host string content and compositions thereof |
| CA2867444C (en) * | 2012-03-16 | 2021-04-13 | University Health Network | Compositions containing soluble toso protein and uses thereof |
| EP2970451A1 (en) * | 2013-03-14 | 2016-01-20 | Amgen Inc. | Chrdl-1 antigen binding proteins and methods of treatment |
| US9493561B2 (en) * | 2013-07-03 | 2016-11-15 | University Health Network | Antibodies to Toso |
| AU2015225867B2 (en) * | 2014-03-07 | 2020-02-06 | University Health Network | Methods and compositions for modifying the immune response |
| CA2961439A1 (en) | 2014-11-05 | 2016-05-12 | Genentech, Inc. | Anti-fgfr2/3 antibodies and methods using same |
| US20180201676A1 (en) | 2015-02-11 | 2018-07-19 | University Health Network | Methods and compositions for modulating lilr proteins |
| ES2690420T3 (es) * | 2015-05-28 | 2018-11-20 | Universität Zu Köln | Receptor de antígeno quimérico anti-toso y su uso |
| WO2018119425A2 (en) | 2016-12-22 | 2018-06-28 | Icahn School Of Medicine At Mount Sinai | Anti-lilrb3 antibodies and methods of use thereof |
| MX2021009767A (es) | 2019-02-15 | 2021-11-17 | Univ Health Network | Moleculas de union de fmcr y usos de las mismas. |
-
2020
- 2020-02-14 MX MX2021009767A patent/MX2021009767A/es unknown
- 2020-02-14 BR BR112021016102A patent/BR112021016102A2/pt unknown
- 2020-02-14 EP EP20756467.5A patent/EP3924388A4/en active Pending
- 2020-02-14 SG SG11202108837WA patent/SG11202108837WA/en unknown
- 2020-02-14 US US17/430,311 patent/US12286476B2/en active Active
- 2020-02-14 WO PCT/CA2020/050195 patent/WO2020163962A1/en not_active Ceased
- 2020-02-14 CA CA3130225A patent/CA3130225A1/en active Pending
- 2020-02-14 CN CN202080025378.0A patent/CN113993895A/zh active Pending
- 2020-02-14 TW TW109104713A patent/TWI857009B/zh active
- 2020-02-14 EA EA202192254A patent/EA202192254A1/ru unknown
- 2020-02-14 KR KR1020217029786A patent/KR20210139273A/ko not_active Ceased
- 2020-02-14 JP JP2021547401A patent/JP2022520817A/ja active Pending
- 2020-02-14 AU AU2020222408A patent/AU2020222408A1/en active Pending
-
2021
- 2021-08-12 IL IL285585A patent/IL285585A/en unknown